Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Moreno B, Lopez I, Fernández-Díez B, Gottlieb M, Matute C, Sánchez-Gómez MV, Domercq M, Giralt A, Alberch J, Collon KW, Zhang H, Parent JM, Teixido M, Giralt E, Ceña V, Posadas I, Martínez-Pinilla E, Villoslada P, Franco R. Moreno B, et al. PLoS One. 2014 Mar 5;9(3):e90671. doi: 10.1371/journal.pone.0090671. eCollection 2014. PLoS One. 2014. PMID: 24599318 Free PMC article.
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.
Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A. Villoslada P, et al. Among authors: moreno b. Neurotherapeutics. 2019 Jul;16(3):808-827. doi: 10.1007/s13311-019-00717-4. Neurotherapeutics. 2019. PMID: 30815844 Free PMC article.
Methylthioadenosine reverses brain autoimmune disease.
Moreno B, Hevia H, Santamaria M, Sepulcre J, Muñoz J, García-Trevijano ER, Berasain C, Corrales FJ, Avila MA, Villoslada P. Moreno B, et al. Ann Neurol. 2006 Sep;60(3):323-34. doi: 10.1002/ana.20895. Ann Neurol. 2006. PMID: 16786535 Free article. Clinical Trial.
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B, Melero I, Bendandi M, Villoslada P. Martinez-Forero I, et al. Among authors: moreno b. Eur J Immunol. 2008 Feb;38(2):576-86. doi: 10.1002/eji.200737271. Eur J Immunol. 2008. PMID: 18200504 Free article.
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.
Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, Gabilondo I, Martínez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fernández B, Bullich S, Sánchez-Dalmau B, Graus F, Villoslada P, Saiz A. Llufriu S, et al. Among authors: moreno b. PLoS One. 2014 Dec 1;9(12):e113936. doi: 10.1371/journal.pone.0113936. eCollection 2014. PLoS One. 2014. PMID: 25436769 Free PMC article. Clinical Trial.
495 results